MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells
Open Access
- 3 July 2007
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 97 (3) , 358-367
- https://doi.org/10.1038/sj.bjc.6603863
Abstract
Membrane-type 1 matrix metalloproteinase (MT1-MMP), a transmembrane metalloprotease that plays an important role in the invasion of many solid tumour types, promotes pericellular matrix degradation and may also stimulate tumour cell motility. As both these processes are key contributors to intraperitoneal ovarian tumour metastasis, we examined six ovarian cancer cell lines to determine whether MT1 is a critical mediator of invasive behaviour for this tumour type. Our results indicated that only those cell lines that expressed MT1 were capable of penetrating a type I collagen barrier, with the capacity for both matrix degradation and invasion reflecting endogenous MT1 expression level. Ectopic MT1 expression endowed an invasive phenotype upon cell lines lacking MT1 that were previously non-invasive, indicating the crucial role of this protease. Conversely, invasion was abolished by tissue inhibitor of metalloproteinase-2 (TIMP-2), a potent inhibitor of MT1, yet was minimally affected when other (secreted) MMPs were inhibited using TIMP-1 and the gelatinase inhibitor SB-3CT. Whereas collagen I degradation was strikingly accelerated by ectopic MT1 expression, cell motility remained unchanged. We conclude that MT1 is necessary for collagen I invasion by ovarian cancer cells, and that its requisite activity is the promotion of matrix degradation, with no impact on cell motility.Keywords
This publication has 70 references indexed in Scilit:
- A cancer cell metalloprotease triad regulates the basement membrane transmigration programGenes & Development, 2006
- Effects of Histone Deacetylase Inhibitor (HDACi); Trichostatin-A (TSA) on the expression of housekeeping genesMolecular and Cellular Probes, 2006
- Clinical Evaluation of E-cadherin Expression and its Regulation Mechanism in Epithelial Ovarian CancerClinical & Experimental Metastasis, 2006
- Reciprocal interactions between adhesion receptor signaling and MMP regulationCancer and Metastasis Reviews, 2006
- Dissecting the Role of Matrix Metalloproteinases (MMP) and Integrin αvβ3 in AngiogenesisIn vitro: Absence of Hemopexin C Domain Bioactivity, but Membrane-Type 1-MMP and αvβ3 Are CriticalCancer Research, 2005
- Distinct Roles for the Catalytic and Hemopexin Domains of Membrane Type 1-Matrix Metalloproteinase in Substrate Degradation and Cell MigrationJournal of Biological Chemistry, 2004
- Prinomastat, a hydroxamate inhibitor of matrix metalloproteinases, has a complex effect on migration of breast carcinoma cellsInternational Journal of Cancer, 2003
- Processing of Integrin αv Subunit by Membrane Type 1 Matrix Metalloproteinase Stimulates Migration of Breast Carcinoma Cells on Vitronectin and Enhances Tyrosine Phosphorylation of Focal Adhesion KinaseJournal of Biological Chemistry, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Mutation Analysis of Membrane Type-1 Matrix Metalloproteinase (MT1-MMP)Journal of Biological Chemistry, 2001